ASBP (Aspire Biopharma Holdings, Inc. Common Stock) Stock Analysis - Politician Trades
Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.95 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ASBP stock?
Rallies tracks politician and congressional stock disclosures for ASBP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Fell Donald G. bought 10.50K (~$4.09K) on Jun 5, 2025.
Fell Donald G. sold 10.50K (~$4.09K) on Jun 5, 2025.
Fell Donald G. bought 9.50K (~$3.71K) on Jun 4, 2025.
ASBP Analyst Consensus
ASBP analyst coverage data. Average price target: $0.00.
Common questions about ASBP
Which politicians traded ASBP stock?
Rallies tracks politician and congressional stock disclosures for ASBP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ASBP?
Yes. Rallies tracks politician and congressional stock disclosures for ASBP, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ASBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.